drugset / Trial / NCT04837924

Fascia Iliaca Compartment Block for Pain Management in Hip Fracture Patients

NCT04837924

Phase 4 Completed 80 enrolled General Hospital Sveti Duh
RandomizedParallel-groupTriple-blindTreatment

Summary

BLOCKPAIN is a randomized controlled study, 80 participants. The participants will be hip fracture patients in Emergency Medicine Department in Clinical Hospital "Sveti Duh", Zagreb, Croatia. Upon patient arrival inclusion and exclusion criteria will be established. After signing the informed consent form participant will be randomized in one of two study groups. One study group is fascia iliaca compartment block (FICB), the other is placebo. All participants will be given paracetamol 1 gram IV as standard care. If needed, rescue analgesic will be tramadol 100 mg in 100 ml saline IV. The time frame is 24 hours after the FICB or placebo procedure.

Timeline

Start
2021-04-21
Primary completion
2022-05-26
Completion
2022-05-27

Drugs

EvaluationDrugModalityDoseRoute
Background Acetaminophen Small molecule 1 g Intravenous
Background Tramadol Other / unclassified 100 mg Intravenous

Indications

No indication recorded.